GHK-Cu + BPC-157 Stack
A copper-peptide and a gastric-derived cytoprotective peptide — researched together for skin remodeling, scar reduction, and connective-tissue repair.
Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Why these two are stacked
GHK-Cu modulates roughly 4,000 human genes — upregulating collagen and elastin synthesis, antioxidant defense, and stem cell activation, while downregulating inflammatory pathways. BPC-157 adds angiogenesis and GH-receptor upregulation in injured tissue. Together the pair is researched for situations where skin or connective tissue needs both extracellular-matrix rebuilding (GHK-Cu) and improved vascular supply (BPC-157).
GHK-Cu is the matrix remodeler; BPC-157 is the blood-supply restorer. The two act on largely non-overlapping pathways, which is why research combines them for chronic wounds, post-surgical scar reduction, and scalp / hair-follicle support.
Researched together for
- •Collagen and elastin synthesis (GHK-Cu)
- •Capillary regrowth and angiogenesis (BPC-157)
- •Hair follicle stimulation (GHK-Cu)
- •Chronic wound and ulcer models
- •Post-surgical scar remodeling
Sample weekly schedule
| When | Research protocol |
|---|---|
| Topical GHK-Cu | Daily AM application of a copper-peptide serum (research formulations typically 1–3 mg/mL). |
| Subcutaneous BPC-157 | Once-daily SC dose near the affected area; cycles of 4–8 weeks. |
| Injectable GHK-Cu | Some protocols add SC GHK-Cu (1–2 mg, 3–5× weekly) for systemic skin and hair effects. |
Timing notes
- •Topical GHK-Cu is best applied to clean skin before occlusive products.
- •BPC-157 timing is not food-dependent for skin/wound research.
- •Copper levels should not be over-supplemented elsewhere when running injectable GHK-Cu.
Stack-specific considerations
- •Neither peptide is FDA-approved for these indications.
- •GHK-Cu is well-tolerated topically but can irritate sensitive skin.
- •BPC-157 evidence in humans remains limited; preclinical models dominate.
- •Active malignancy is a relative contraindication due to angiogenic effects.
Frequently asked
Q.Why combine GHK-Cu and BPC-157 for skin work?
GHK-Cu rebuilds the extracellular matrix (collagen, elastin) while BPC-157 restores blood supply. Together the pair targets both the structural and circulatory components of skin repair.
Q.Is topical GHK-Cu enough, or do I need injections?
Topical GHK-Cu is well-supported for surface skin effects. Injectable is researched for hair, deeper dermal remodeling, and systemic anti-aging signaling — but less studied in humans.
Q.Can this stack help with stretch marks or scars?
Research supports GHK-Cu for scar remodeling and dermal repair. Combining with BPC-157 is hypothesized to improve outcomes in chronic or vascularly-compromised scars.
Q.Will the stack regrow hair?
GHK-Cu has hair-follicle research support; BPC-157 adds local blood-supply benefit. Neither replaces FDA-approved options like minoxidil or finasteride in evidence weight.
Q.Are copper peptides safe long-term?
Topical GHK-Cu has a long safety record. Long-term systemic copper-peptide research is more limited; copper status should be monitored.
Q.Can this stack be combined with retinoids?
Yes, but separate application by several hours — low-pH retinoids can destabilize copper-peptide complexes.
Q.How long until skin changes are visible in research?
Topical GHK-Cu studies typically show measurable elasticity and roughness improvements at 8–12 weeks of consistent use.